Michael Schenk

No ORCID on file · 4 papers in corpus
rct 2024
BEYOND: a randomized controlled trial comparing efficacy and safety of individualized follitropin delta dosing in a GnRH agonist versus antagonist protocol during the first ovarian stimulation cycle
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deae092

STUDY QUESTION: How does a gonadotrophin-releasing hormone (GnRH) agonist versus a GnRH antagonist protocol affect ovarian response when using an individualized fixed daily dose of follitropin delta for ovarian stimulation? SUMMARY ANSWER:…

other 2022
Confirmation of human ovulation in assisted reproduction using an adhesive axillary thermometer (femSense®)
Frontiers in digital health ·doi:10.3389/fdgth.2022.930010

OBJECTIVE: Timing for sexual intercourse is important in achieving pregnancy in natural menstrual cycles. Different methods of detecting the fertile window have been invented, among them luteinization hormone (LH) to predict ovulation and b…

observational 2021
Pronounced Trace Element Variation in Follicular Fluids of Subfertile Women Undergoing Assisted Reproduction
Nutrients ·doi:10.3390/nu13114134

Female subfertility is a growing concern, especially in view of an increasing prevalence of polycystic ovary syndrome (PCOS). Assisted reproductive technologies (ART) offer a perspective for pregnancy, but the outcome rate is still suboptim…

observational 2019
Endometriosis accelerates synchronization of early embryo cell divisions but does not change morphokinetic dynamics in endometriosis patients
PloS one ·doi:10.1371/journal.pone.0220529

OBJECTIVE: The pathology of endometriosis and its impact on embryo development is still a black box in reproductive medicine. In this time-lapse study we investigated the influence of endometriosis on morphokinetic parameters of embryo deve…